Maven Bio

Live intelligence for biopharma teams.

3.2Score#314 of 999 agents#4 of 11 in Market researcher

Why it ranks #314

Maven Bio, an AI market researcher from YC S23, ranks #314 of 999 AI agents and #4 of 11 in Market researcher, with a score of 3.2 of 10. Data as of 3 Oct 2026.

The score adds four parts, each 0 to 10, by weight. Every point comes from public evidence. How scoring works ·

Proof 2 × 30% 0.6
Scale 4 × 30% 1.2
Momentum 2 × 25% 0.5
Autonomy 6 × 15% 0.9
= 3.2

Proof
Do customers use it? 30% of the score
2
Claims a customer count.
- +2
  A customer count
  “Join hundreds of users from the world's top BioPharma companies, consultancies, and venture capital firms and try our robust free tier at mavenbio.io”
  Launch YC post · 4 Nov 2024 · 2 claims
Not found: revenue or growth (+4), named customers (+3), a customer result (+2), work done at scale (+2)
Scale
Is there a real company behind it? 30% of the score
4
10 people.
- +4
  10 people on its YC page10 to 19 people
Not found: funding round in its news (+3)
Momentum
Is it shipping and growing now? 25% of the score
2
Shows hiring.
- +2
  Hiring: 1 open roleSenior SDRYC page
Not found: launch YC post in the last 6 months (+3), new traction claim in the last 6 months (+2), funding news in the last year (+2), a batch in the last year (it is YC Summer 2023) (+1)
Autonomy
How much of the job does it do on its own? 15% of the score
6
Supervised agent: takes actions in other systems; a person approves key steps.
- +6
  Level 2 of 4: Supervised agentTakes actions in other systems; a person approves key steps.
What the model read
- Acts in other systems: 80% likely
- Finishes whole tasks: 17% likely
- Calls itself an agent: 36% likely
Level 2: Takes actions in other systems; a person approves key steps.

About Maven Bio

Maven Bio is a live intelligence platform for biopharma teams. It continuously monitors clinical, regulatory, company, and deal developments, identifies what matters to each team's priorities, and delivers signals and updates to keep key documents current. Its monitoring agent can apply edits automatically, with sources attached and the option to roll back changes.

Maven runs thousands of monitors across company and individual product websites, trade press, health technology assessment bodies, and patient advocacy groups worldwide. Teams use that intelligence to maintain competitive views, asset screens, and recurring briefs, in Maven or through connected AI assistants and custom workflows.